January 20, 2022
“…Vontier (VNT)… In light of these comments, Raso rates Vontier an Outperform (i.e. Buy), and his $42 price target implies an upside of ~40% for the year ahead… Overall, there are 3 analyst reviews on record for this stock, and they… Continue Reading…
August 5, 2021
“NexPoint Real Estate Finance (NREF)… There are only two recent reviews on record for NREF shares, but they both agree – this is a stock to buy. Their agreement gives the shares their Moderate Buy consensus rating. NREF is trading for… Continue Reading…
July 28, 2021
“Mimecast, Ltd. (MIME)… Overall, MIME derives its Strong Buy consensus rating from 10 reviews, including 8 Buys and 2 Holds. The shares are trading for $55.24 and their $62.90 average price target suggests room for another 14% in price appreciation. Super… Continue Reading…
March 23, 2021
“Iovance Biotherapeutics (IOVA)… The cutting edge med tech has attracted attention from Pantginis’ colleagues, as well. The stock has 5 recent reviews, and all are to Buy, making for a unanimous Strong Buy analyst consensus rating. IOVA has an average… Continue Reading…
March 2, 2021
“According to analysts, these are the top 3 penny stocks to buy right now: Super League Gaming Inc. (NASDAQ: SLGG) ReWalk Robotics Ltd. (NASDAQ: RWLK) Fortress Biotech Inc. (NASDAQ: FBIO) One of the biotech penny stocks we’ve discussed frequently has been Fortress Biotech Inc. (NASDAQ: FBIO). This biotech penny… Continue Reading…
March 2, 2021
“Ellington Financial (EFC)… There is general agreement on Wall Street that EFC is a quality investment, and the analyst consensus rating shows that: it is a unanimous Strong Buy, based on 4 recent reviews. The shares are priced at $15.77,… Continue Reading…
February 25, 2021
“TechnipFMC Plc (FTI)… Overall, there are 13 recent reviews on FTI, breaking down 8 to 5 in favor of Buy versus Hold. This makes the analyst consensus rating a Moderate Buy, and suggests that Wall Street generally sees opportunity here. Shares… Continue Reading…
February 24, 2021
“Avalara, Inc. (AVLR)… Of the 11 analysts who have reviewed Avalara in recent weeks, 10 agree with Bracelin that this is a stock to buy, and this breakdown of 10 Buys to 1 Hold gives the company a Strong Buy analyst… Continue Reading…
February 17, 2021
“Cortexyme, Inc. (CRTX)… Overall, Cortexyme has a Moderate Buy rating from the analyst consensus, with 6 recent reviews breaking down 4 to 1 to 1, Buy-Hold-Sell. The stock’s $83.60 average price target suggests that Wall Street sees a high potential here,… Continue Reading…
Recent Comments